Related Experiment Video
Updated: Jul 19, 2026

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis
Katherine Hope Kenyon1,2, Frederique Boonstra3, Gustavo Noffs3,4,5,6
1Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia. katherine.kenyon@monash.edu.
Abstract:
Multiple sclerosis (MS) is a progressive disease that often affects the cerebellum. It is characterised by demyelination, inflammation, and neurodegeneration within the central nervous system. Damage to the cerebellum in MS is associated with increased disability and decreased quality of life. Symptoms include gait and balance problems, motor speech disorder, upper limb dysfunction, and oculomotor difficulties. Monitoring symptoms is crucial for effective management of MS. A combination of clinical, neuroimaging, and task-based measures is generally used to diagnose and monitor MS. This paper reviews the present and new tools used by clinicians and researchers to assess cerebellar impairment in people with MS (pwMS). It also describes recent advances in digital and home-based monitoring for people with MS.

